Published in AIDS on September 24, 2015
Trial of Collaborative Depression Care Management for HIV Patients (SLAM DUNC) | NCT01372605
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel. JAMA (2016) 2.23
Mechanisms for the Negative Effects of Internalized HIV-Related Stigma on Antiretroviral Therapy Adherence in Women: The Mediating Roles of Social Isolation and Depression. J Acquir Immune Defic Syndr (2016) 0.88
The Impact of Mental Wellness on HIV Self-Management. J Assoc Nurses AIDS Care (2016) 0.76
Improving Depression Among HIV-Infected Adults: Transporting the Effect of a Depression Treatment Intervention to Routine Care. J Acquir Immune Defic Syndr (2016) 0.75
Attitudes of Indian HIV Clinicians Toward Depression in People Living with HIV. Ann Glob Health (2017) 0.75
Cognitive behavioural therapy for adherence and depression in patients with HIV: a three-arm randomised controlled trial. Lancet HIV (2016) 0.75
Comparative effectiveness of dual vs single-action antidepressants on HIV clinical outcomes in HIV-infected people with depression. AIDS (2017) 0.75
Association between Perceived Discrimination in Healthcare Settings and HIV Medication Adherence: Mediating Psychosocial Mechanisms. AIDS Behav (2017) 0.75
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med (2001) 76.04
A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care (1996) 70.87
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11
Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry (2001) 7.30
Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA (2001) 5.52
Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry (2001) 5.22
Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS (1999) 4.39
Collaborative care for depression and anxiety problems. Cochrane Database Syst Rev (2012) 4.21
Lessons for cluster randomized trials in the twenty-first century: a systematic review of trials in primary care. Clin Trials (2004) 4.19
Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr (2011) 3.54
A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol (2009) 3.26
Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med (2005) 2.83
Intraclass correlation coefficients for cluster randomized trials in primary care: data from the MRC Trial of the Assessment and Management of Older People in the Community. Control Clin Trials (2002) 2.36
Progression to AIDS: the effects of stress, depressive symptoms, and social support. Psychosom Med (1999) 2.36
Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr (2008) 2.35
Barriers to antiretroviral adherence: the importance of depression, abuse, and other traumatic events. AIDS Patient Care STDS (2006) 2.30
Rating depressive patients. J Clin Psychiatry (1980) 2.27
Underdiagnosis of depression in HIV: who are we missing? J Gen Intern Med (2003) 2.21
Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone. J Gen Intern Med (2007) 2.15
Visual analog scale of ART adherence: association with 3-day self-report and adherence barriers. J Acquir Immune Defic Syndr (2006) 2.12
Cost-effectiveness of treatments for major depression in primary care practice. Arch Gen Psychiatry (1998) 2.11
Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J Acquir Immune Defic Syndr (2006) 2.01
Use of mental health and substance abuse treatment services among adults with HIV in the United States. Arch Gen Psychiatry (2001) 1.98
Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol (2012) 1.94
Self-rated global measure of the frequency, intensity, and burden of side effects. J Psychiatr Pract (2006) 1.89
A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. J Acquir Immune Defic Syndr (2006) 1.85
Intraclass correlation coefficients for cluster randomized trials in primary care: the cholesterol education and research trial (CEART). Contemp Clin Trials (2005) 1.69
A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV. Arch Gen Psychiatry (2010) 1.66
Re-estimating the prevalence of psychiatric disorders in a nationally representative sample of persons receiving care for HIV: results from the HIV Cost and Services Utilization Study. Int J Methods Psychiatr Res (2002) 1.39
Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care. Neuropsychopharmacology (2007) 1.39
Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men. A 2-year follow-up study. Arch Gen Psychiatry (1997) 1.36
Efficacy of antidepressant medication among HIV-positive individuals with depression: a systematic review and meta-analysis. AIDS Patient Care STDS (2005) 1.33
Estimating remission from untreated major depression: a systematic review and meta-analysis. Psychol Med (2012) 1.33
Depression treatment enhances adherence to antiretroviral therapy: a meta-analysis. Ann Behav Med (2014) 1.32
Effectiveness of collaborative care for depression in human immunodeficiency virus clinics. Arch Intern Med (2011) 1.31
Efficacy of group psychotherapy to reduce depressive symptoms among HIV-infected individuals: a systematic review and meta-analysis. AIDS Patient Care STDS (2007) 1.21
Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population. Psychosom Med (2008) 1.19
Treating depression within the HIV "medical home": a guided algorithm for antidepressant management by HIV clinicians. AIDS Patient Care STDS (2012) 1.18
Directly observed antidepressant medication treatment and HIV outcomes among homeless and marginally housed HIV-positive adults: a randomized controlled trial. Am J Public Health (2012) 1.18
A review of studies of the Hamilton depression rating scale in healthy controls: implications for the definition of remission in treatment studies of depression. J Nerv Ment Dis (2004) 1.14
Assessing the effect of Measurement-Based Care depression treatment on HIV medication adherence and health outcomes: rationale and design of the SLAM DUNC Study. Contemp Clin Trials (2012) 1.14
How should we measure medication adherence in clinical trials and practice? Ther Clin Risk Manag (2007) 1.12
Pseudo cluster randomization: a treatment allocation method to minimize contamination and selection bias. Stat Med (2005) 1.10
Predictors of AIDS-related morbidity and mortality in a southern U.S. Cohort. AIDS Patient Care STDS (2007) 1.09
Falling through the cracks: the gaps between depression prevalence, diagnosis, treatment, and response in HIV care. AIDS (2012) 1.09
Reliability and validity of depression assessment among persons with HIV in sub-Saharan Africa: systematic review and meta-analysis. J Acquir Immune Defic Syndr (2014) 1.03
A preliminary RCT of CBT-AD for adherence and depression among HIV-positive Latinos on the U.S.-Mexico border: the Nuevo Día study. AIDS Behav (2013) 1.01
Generalist care managers for the treatment of depressed medicaid patients in North Carolina: a pilot study. BMC Fam Pract (2007) 0.99
Estimates of intraclass correlation for variables related to behavioral HIV/STD prevention in a predominantly African American and Hispanic sample of young women. Health Educ Behav (2009) 0.93
Providers' attitudes towards treating depression and self-reported depression treatment practices in HIV outpatient care. AIDS Patient Care STDS (2013) 0.92
Depression-free day to utility-weighted score: is it valid? Med Care (2007) 0.91
Telephone based cognitive behavioral therapy targeting major depression among urban dwelling, low income people living with HIV/AIDS: results of a randomized controlled trial. AIDS Behav (2013) 0.85
Pseudo cluster randomization dealt with selection bias and contamination in clinical trials. J Clin Epidemiol (2006) 0.84
Balancing Contamination and Referral Bias in a Randomized Clinical Trial: An Application of Pseudo-Cluster Randomization. Am J Epidemiol (2015) 0.76
Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol (2005) 8.67
Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2002) 7.78
Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med (2012) 7.04
Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis (2009) 4.96
The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry (2005) 4.45
Screening for depression in adult patients in primary care settings: a systematic evidence review. Ann Intern Med (2009) 4.17
The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS (2009) 3.78
Distribution of health care expenditures for HIV-infected patients. Clin Infect Dis (2006) 3.72
Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clin Infect Dis (2007) 3.46
Early retention in HIV care and viral load suppression: implications for a test and treat approach to HIV prevention. J Acquir Immune Defic Syndr (2012) 2.74
Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians. Ann Intern Med (2008) 2.65
Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials. Clin Infect Dis (2014) 2.65
Racial disparities in HIV virologic failure: do missed visits matter? J Acquir Immune Defic Syndr (2009) 2.58
Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002. Clin Infect Dis (2004) 2.42
Failure to establish HIV care: characterizing the "no show" phenomenon. Clin Infect Dis (2007) 2.37
Screening for and treatment of suicide risk relevant to primary care: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med (2013) 2.36
Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Ann Intern Med (2011) 2.31
Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2008) 2.29
Deployment and the use of mental health services among U.S. Army wives. N Engl J Med (2010) 2.21
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med (2012) 2.18
Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy. AIDS (2008) 2.13
Church attendance in men who have sex with men diagnosed with HIV is associated with later presentation for HIV care. Clin Infect Dis (2013) 2.06
Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2007) 2.02
Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J Acquir Immune Defic Syndr (2006) 2.01
How trauma, recent stressful events, and PTSD affect functional health status and health utilization in HIV-infected patients in the south. Psychosom Med (2005) 1.98
Validation, performance under field conditions, and cost-effectiveness of Capillus HIV-1/HIV-2 and determine HIV-1/2 rapid human immunodeficiency virus antibody assays using sequential and parallel testing algorithms in Tanzania. J Clin Microbiol (2008) 1.94
Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis (2013) 1.94
Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy. Clin Infect Dis (2011) 1.91
Fool's gold: Why imperfect reference tests are undermining the evaluation of novel diagnostics: a reevaluation of 5 diagnostic tests for leptospirosis. Clin Infect Dis (2012) 1.91
Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med (2015) 1.86
Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Ann Intern Med (2005) 1.83
Factors associated with fewer visits for HIV primary care at a tertiary care center in the Southeastern U.S. AIDS Care (2006) 1.76
Who tests, who doesn't, and why? Uptake of mobile HIV counseling and testing in the Kilimanjaro Region of Tanzania. PLoS One (2011) 1.73
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis. J Acquir Immune Defic Syndr (2013) 1.72
The influence of psychosocial characteristics and race/ethnicity on the use, duration, and success of antiretroviral therapy. J Acquir Immune Defic Syndr (2008) 1.72
Relation of lifetime trauma and depressive symptoms to mortality in HIV. Am J Psychiatry (2007) 1.68
A systematic review and meta-regression of temporal trends in adult CD4(+) cell count at presentation to HIV care, 1992-2011. Clin Infect Dis (2013) 1.67
Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report. Am J Psychiatry (2007) 1.67
Deployment and mental health diagnoses among children of US Army personnel. Arch Pediatr Adolesc Med (2011) 1.66
Interventions to prevent post-traumatic stress disorder: a systematic review. Am J Prev Med (2013) 1.64
Copy-years viremia as a measure of cumulative human immunodeficiency virus viral burden. Am J Epidemiol (2009) 1.63
Increase in work productivity of depressed individuals with improvement in depressive symptom severity. Am J Psychiatry (2013) 1.61
A comparison of the wellbeing of orphans and abandoned children ages 6-12 in institutional and community-based care settings in 5 less wealthy nations. PLoS One (2009) 1.56
Aging with HIV: a cross-sectional study of comorbidity prevalence and clinical characteristics across decades of life. J Assoc Nurses AIDS Care (2010) 1.55
Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy. AIDS (2011) 1.52
Routine, self-administered, touch-screen, computer-based suicidal ideation assessment linked to automated response team notification in an HIV primary care setting. Clin Infect Dis (2010) 1.51
Invasive disease caused by nontuberculous mycobacteria, Tanzania. Emerg Infect Dis (2009) 1.51
Duration of highly active antiretroviral therapy regimens. Clin Infect Dis (2003) 1.50
Biopsychosocial benefits of spirituality in adults aging with HIV: implications for nursing practice and research. J Holist Nurs (2008) 1.47
Missed office visits and risk of mortality among HIV-infected subjects in a large healthcare system in the United States. AIDS Patient Care STDS (2013) 1.43
A low-effort, clinic-wide intervention improves attendance for HIV primary care. Clin Infect Dis (2012) 1.42
Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV. AIDS Behav (2013) 1.41
STAR*D: revising conventional wisdom. CNS Drugs (2009) 1.41
Depression, sexually transmitted infection, and sexual risk behavior among young adults in the United States. Arch Pediatr Adolesc Med (2009) 1.41
Antiretroviral prescribing patterns in treatment-naïve patients in the United States. AIDS Patient Care STDS (2010) 1.40
Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care. Neuropsychopharmacology (2007) 1.39
Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. Am J Psychiatry (2009) 1.38
Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care. AIDS (2012) 1.38
Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs. Patient Prefer Adherence (2011) 1.37
Minorities, the poor, and survivors of abuse: HIV-infected patients in the US deep South. South Med J (2007) 1.36
Essential components of effective HIV care: a policy paper of the HIV Medicine Association of the Infectious Diseases Society of America and the Ryan White Medical Providers Coalition. Clin Infect Dis (2011) 1.36
Shifting the paradigm: using HIV surveillance data as a foundation for improving HIV care and preventing HIV infection. Milbank Q (2013) 1.33
Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients. AIDS (2007) 1.33
Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in Tanzania. AIDS Res Hum Retroviruses (2009) 1.32
Analysis of traumatic injuries presenting to a referral hospital emergency department in Moshi, Tanzania. Int J Emerg Med (2012) 1.31
Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy. Clin Infect Dis (2013) 1.31
Overload: impact of incident stressful events on antiretroviral medication adherence and virologic failure in a longitudinal, multisite human immunodeficiency virus cohort study. Psychosom Med (2009) 1.30
Multimorbidity patterns in HIV-infected patients: the role of obesity in chronic disease clustering. J Acquir Immune Defic Syndr (2012) 1.30
Longitudinal effects of SafeTalk, a motivational interviewing-based program to improve safer sex practices among people living with HIV/AIDS. AIDS Behav (2012) 1.28
Pain, mood, and substance abuse in HIV: implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failure. J Acquir Immune Defic Syndr (2012) 1.27
Joint effects of alcohol consumption and high-risk sexual behavior on HIV seroconversion among men who have sex with men. AIDS (2013) 1.27
Nucleoside reverse-transcriptase inhibitor dosing errors in an outpatient HIV clinic in the electronic medical record era. Clin Infect Dis (2007) 1.26
SafeTalk, a multicomponent, motivational interviewing-based, safer sex counseling program for people living with HIV/AIDS: a qualitative assessment of patients' views. AIDS Patient Care STDS (2010) 1.24
High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010. J Acquir Immune Defic Syndr (2013) 1.23
Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis. Drug Saf (2008) 1.20
Treating depression within the HIV "medical home": a guided algorithm for antidepressant management by HIV clinicians. AIDS Patient Care STDS (2012) 1.18